stimulation of hiv-1-neutralizing antibodies in simian hiv-iiib-infected macaques.

NLM AIDSLINE Stimulation of HIV-1-neutralizing antibodies in simian HIV-IIIB-infected macaques. Muller S; Margolin DH; Nara PL; Alvord WG; Kohler H; Immpheron, Inc.,
April 30, 1998

Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):276-81. Unique Identifier : Previously we have discovered a public idiotope, designated 1F7, that is expressed on antibodies against HIV type 1 (HIV-1) in human and nonhuman primates. To test the potential of mouse monoclonal antibody (mAb) 1F7 as a therapeutic anti-clonotypic antibody in HIV-1-infected patients, we used the simian HIV-IIIB macaque infection model, which mimics several immunological and pathological characteristics of HIV-1 infection in humans. Four healthy simian HIV-infected rhesus monkeys (Macaca mulatta) expressing the 1F7 marker on anti-gp120 antibodies were selected for this study. Three monkeys of this group were immunized several times with the murine mAb 1F7 i.v., and one monkey received as control an isotype-matched antibody, TEPC183. No serious side effect or allergic reaction was encountered. Blood collected before and during the immunization and over several months afterward were analyzed for neutralizing antibodies. Significant increases in breadth and potency of HIV-1-neutralizing antibody titers to one or more virus strains were detected in all three of the 1F7-immunized monkeys, but not in the control monkey immunized with TEPC183. These results show that an antibody, recognizing a public idiotope associated with anti-HIV-1 antibodies can function in chronically infected primates as an anti-clonotypic immunogen to boost antibodies that neutralize homologous and heterologous virus strains. This study represents a first step toward the preclinical evaluation of 1F7 as a therapeutic AIDS vaccine. AIDS Vaccines/IMMUNOLOGY HIV Antibodies/BIOSYNTHESIS HIV Envelope Protein gp120/IMMUNOLOGY HIV-1/IMMUNOLOGY *Vaccines, Synthetic/IMMUNOLOGY

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CALIFORNIA: Over Half of People Living with AIDS in San Francisco Are Aged 50 or Older THAILAND; UNITED STATES: HIV Drug Can Also Protect Injection Drug Users INDONESIA: Growing HIV/AIDS Awareness in Indonesia's Papua Region UNITED STATES: Many Young Americans Unaware They're Infected with HIV Board to Vote on Condoms in Boston Schools New International Report on HIV Prevention Urges Localized Consideration of Antiretroviral Strategies UNAIDS and Lancet to bring together political and health leaders to shape the debate on the future of global health Cambodia Trains Social Workers to Curb Reliance on Foreign Aid New Hampshire nears approval of medical marijuana law Celebrating 10 years of PEPFAR THAILAND; UNITED STATES: HIV Drug Can Also Protect Injection Drug Users INDONESIA: Growing HIV/AIDS Awareness in Indonesia's Papua Region UNITED STATES: Many Young Americans Unaware They're Infected with HIV New International Report on HIV Prevention Urges Localized Consideration of Antiretroviral Strategies New Analysis of World's Premier AIDS Conference Finds Poor Coverage of Populations Most-at-Risk for HIV GREECE: Doubled HIV Cases Add to Greek Woes OHIO: Phila Health Department HIV Testing Well-Received CONNECTICUT: City's Circle Care Center is a Model for HIV Prevention TAIWAN: HIV/AIDS Spreading to Younger People in Taiwan FLORIDA: Groups Offering Free HIV Testing
Information in this article was accurate in April 30, 1998. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.